{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:41:25Z","timestamp":1786545685176,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1111\/j.1572-0241.2008.02117.x","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T12:13:09Z","timestamp":1220530389000},"page":"2432-2442","source":"Crossref","is-referenced-by-count":15,"title":["Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett's Esophagus"],"prefix":"10.14309","volume":"103","author":[{"given":"Chin","family":"Hur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy E.","family":"Broughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa","family":"Ozanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yachimski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman S.","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Scott","family":"Gazelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: A systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1442-2050.2007.00684.x","article-title":"Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus","volume":"20","author":"Jacobson","year":"2007","journal-title":"Dis Esophagus"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jnci\/94.6.422","article-title":"The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: An in vitro study","volume":"94","author":"Buttar","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","article-title":"Celecoxib for the prevention of colorectal adenomatous polyps","volume":"355","author":"Arber","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-142-3-200502010-00005","article-title":"Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction","volume":"142","author":"Kimmel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study","volume":"321","author":"Steering Committee of the Physicians' Health Study Research Group","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/heart.85.3.265","article-title":"Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials","volume":"85","author":"Sanmuganathan","year":"2001","journal-title":"Heart"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(98)10279-9","article-title":"Lifetime risk of developing coronary heart disease","volume":"353","author":"Lloyd-Jones","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB11","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB12","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial","volume":"282","author":"Simon","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bmj.325.7365.619","article-title":"Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials","volume":"325","author":"Deeks","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02599636","article-title":"The framing effect of relative and absolute risk","volume":"8","author":"Malenka","year":"1993","journal-title":"J Gen Intern Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0272989X02238296","article-title":"iMPACT3: Internet-based development and administration of utility elicitation protocols","volume":"22","author":"Lenert","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study [see comments]","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB17","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB18","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0016-5085(03)00393-7","article-title":"Medical decision analysis of chemoprevention against esophageal adenocarcinoma","volume":"124","author":"Sonnenberg","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/djh039","article-title":"Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus","volume":"96","author":"Hur","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/cncr.20329","article-title":"The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals","volume":"101","author":"Hur","year":"2004","journal-title":"Cancer"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-144-5-200603070-00007","article-title":"Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: A cost-utility analysis","volume":"144","author":"Pignone","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jnci\/djk112","article-title":"Secondary chemoprevention of Barrett's esophagus with celecoxib: Results of a randomized trial","volume":"99","author":"Heath","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB23","volume-title":"Centre for Health Economics and Policy Analysis Working Paper Series #90-9","author":"Furlong","year":"1990"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.324.7341.827","article-title":"Explaining risks: Turning numerical data into meaningful pictures","volume":"324","author":"Edwards","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/gast.2000.9302","article-title":"Is there publication bias in the reporting of cancer risk in Barrett's esophagus?","volume":"119","author":"Shaheen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gastro.2005.05.055","article-title":"The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program","volume":"129","author":"Shaheen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/gast.2002.32371","article-title":"Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus","volume":"122","author":"Buttar","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB28","first-page":"97","article-title":"Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.STR.0000199613.38911.b2","article-title":"The lifetime risk of stroke: Estimates from the Framingham Study","volume":"37","author":"Seshadri","year":"2006","journal-title":"Stroke"},{"key":"10.1111\/j.1572-0241.2008.02117.x-BIB30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3810\/pgm.1999.03.593","article-title":"Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection?","volume":"105","author":"Graham","year":"1999","journal-title":"Postgrad Med"}],"container-title":["The American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-200810000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:45:13Z","timestamp":1786542313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-200810000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02117.x","relation":{},"ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}